Concepedia

David Sillitti

DS

Statistics

Publications

2

Citations

36

H-Index

2

Active since

2017

Affiliations

Johnson & Johnson (United States)(Current)

David Sillitti is an author at Johnson & Johnson (United States) specializing in cancer immunology, tissue engineering scaffolds, and animal cell culture.

Publications per year

2017–2022

2

Publications

2

FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma

John Reiser, Szeman Ruby Chan, Ketan Mathavan et al. · Blood · 2022 · 24 citations

, , +12

Collagen nanofibre anisotropy induces myotube differentiation and acetylcholine receptor clustering

Frank H. Kung, David Sillitti, Anil Shrirao et al. · Journal of Tissue Engineering and Regenerative Medicine · 2017 · 12 citations

, , +17

1–2 of 2